Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma

Investigational New Drugs

Volumn 28, Issue 5, 2010, Pages 690-693

  Michels, Judith ^a   Lassau, Nathalie ^a   Gross Goupil, Marine ^a   Massard, Christophe ^a   Mejean, Arnaud ^b   Escudier, Bernard ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Renal cell carcinoma; Sunitinib; Tumor lysis syndrome

Indexed keywords

SUNITINIB; ANGIOGENESIS INHIBITOR; INDOLE DERIVATIVE; PYRROLE DERIVATIVE;

ADRENAL TUMOR; ADULT; ARTICLE; ASTHENIA; BRADYCARDIA; CASE REPORT; COMORBIDITY; DIARRHEA; DRUG WITHDRAWAL; HAND FOOT SYNDROME; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; NEPHRECTOMY; PANCREAS RESECTION; PRIORITY JOURNAL; SIDE EFFECT; SLEEP APNEA SYNDROME; SPLENECTOMY; TUMOR LYSIS SYNDROME; VOMITING; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; KIDNEY NEOPLASMS; MIDDLE AGED; RADIOGRAPHY;

ANGIOGENESIS INHIBITORS; HUMANS; INDOLES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PYRROLES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR LYSIS SYNDROME;

EID: 77956057336     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-009-9275-z     Document Type: Article

References (9)

1. N Lassau L Chami B Benatsou P Peronneau A Roche 2007 Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment Eur Radiol 17 6 89 98 10.1007/s10406-007-0233-6 10.1007/s10406-007- 0233-6
2. L Baeksgaard JB Sørensen 2003 Acute tumor lysis syndrome in solid tumors-a case report and review of the literature Cancer Chemother Pharmacol 51 3 187 192 1:STN:280:DC%2BD3s7jvFansg%3D%3D 12655435
3. WY Teo TF Loh AM Tan 2007 Avoiding dialysis in tumour lysis syndrome: is urate oxidase effective? - a case report and review of literature Ann Acad Med Singapore 36 8 679 683 17767339 Review
4. CJ Lin HH Chen RK Hsieh YC Chen CJ Wu 2009 Acute tumor lysis syndrome in a hemodialysis patient with diffuse large B cell lymphoma Med Oncol 26 1 93 95 10.1007/s12032-008-9064-0 10.1007/s12032-008-9064-0 18770053
5. I Rényi E Bárdi E Udvardi G Kovács K Bartyik P Kajtár P Masát K Nagy I Galántai C Kiss 2007 Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's lymphoma Pathol Oncol Res 13 1 57 62 10.1007/BF02893442 10.1007/BF02893442 17387390
6. LQ Chow SG Eckhardt 2007 Sunitinib: from rational design to clinical efficacy J Clin Oncol 25 7 884 896 10.1200/JCO.2006.06.3602 10.1200/JCO.2006.06. 3602 1:CAS:528:DC%2BD2sXjvVKmtLY%3D 17327610 Review
7. RJ Motzer TE Hutson P Tomczak MD Michaelson RM Bukowski O Rixe S Oudard S Negrier C Szczylik ST Kim I Chen PW Bycott CM Baum RA Figlin 2007 Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 2 115 124 10.1056/NEJMoa065044 10.1056/NEJMoa065044 1:CAS:528:DC%2BD2sXksVGqsw%3D%3D 17215529
8. T Nicholaou R Wong ID Davis 2007 Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate Lancet 369 9577 1923 1924 10.1016/S0140-6736(07)60903-9 10.1016/S0140-6736(07)60903-9 17560435
9. PJ Saylor TR Reid 2007 Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib J Clin Oncol 25 23 3544 3546 10.1200/JCO.2007.12.0790 10.1200/JCO.2007.12.0790 17687160